Skip to content

The effects of tecar therapy with biofeedback on the treatment of fecal incontinence in children

Investigating the effects of tecar therapy with biofeedback in comparison with biofeedback alone on the treatment of fecal incontinence in children (4-16 years): a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140811018760N9
Enrollment
81
Registered
2023-06-15
Start date
2023-07-05
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children fecal incontinence. Fecal incontinence

Interventions

Intervention 1: Intervention group 1: biofeedback therapy. Intervention 2: Intervention group 2: biofeedback along with tecar therapy. Intervention 3: Control group: routine medical care.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 16 Years

Inclusion criteria

Inclusion criteria: The age range of children is 4 to 16 years Fecal incontinence for 6 months according to the diagnosis of the referring specialist

Exclusion criteria

Exclusion criteria: Children under 4 years old and over 16 years old Traumatic sphincter injury or following surgery Anorectal and anatomical abnormality of the excretory system or digestive system and sexual disorders Psychological and psychiatric disorders Understanding problems and children who are not able to cooperate with the physiotherapist for any reason. Diseases of the spine or nerves that lead to fecal incontinence Patients with sensory disorders in the anus and perineum

Design outcomes

Primary

MeasureTime frame
The number of bowel incontinence per week. Timepoint: 6 weeks of treatment period, 6 weeks of follow-up. Method of measurement: Report of the patient or the child's parents.;Severity of fecal incontinence. Timepoint: 6 weeks of treatment period, 6 weeks of follow-up. Method of measurement: Rintala questionnaire.;Quality of Life. Timepoint: 6 weeks of treatment period, 6 weeks of follow-up. Method of measurement: Pediatrics Quality of life questionnaire for fecal incontinent.;Severity of constipation. Timepoint: 6 weeks of treatment period, 6 weeks of follow-up. Method of measurement: Pediatrics constipation questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Ghaderi

Tabriz University of Medical Sciences

ghaderimailbox@gmail.com+98 413339771

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026